1. Home
  2. WINA vs NBTX Comparison

WINA vs NBTX Comparison

Compare WINA & NBTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Winmark Corporation

WINA

Winmark Corporation

HOLD

Current Price

$379.55

Market Cap

1.3B

ML Signal

HOLD

Logo Nanobiotix S.A.

NBTX

Nanobiotix S.A.

HOLD

Current Price

$36.75

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WINA
NBTX
Founded
1988
2003
Country
United States
France
Employees
N/A
N/A
Industry
Other Specialty Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.0B
IPO Year
2006
2018

Fundamental Metrics

Financial Performance
Metric
WINA
NBTX
Price
$379.55
$36.75
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$36.00
AVG Volume (30 Days)
31.1K
65.0K
Earning Date
04-15-2026
03-31-2026
Dividend Yield
3.76%
N/A
EPS Growth
3.76
N/A
EPS
2.50
N/A
Revenue
$86,055,700.00
N/A
Revenue This Year
$5.55
$58.17
Revenue Next Year
$6.03
N/A
P/E Ratio
$150.28
N/A
Revenue Growth
5.86
N/A
52 Week Low
$338.18
$4.29
52 Week High
$526.81
$57.14

Technical Indicators

Market Signals
Indicator
WINA
NBTX
Relative Strength Index (RSI) 51.78 44.60
Support Level $358.01 $29.64
Resistance Level $393.93 $41.89
Average True Range (ATR) 13.46 2.57
MACD 3.44 -1.44
Stochastic Oscillator 74.92 13.62

Price Performance

Historical Comparison
WINA
NBTX

About WINA Winmark Corporation

Winmark Corp is a franchisor of value-oriented retail store concepts that buy, sell, and trade gently used merchandise. The company has one reportable segment, including Franchising, and one non-reportable segment, Leasing. The franchising segment franchises value-oriented retail stores that buy, sell, trade, and consign merchandise as well as provide strategic consulting services relating to franchising. The leasing segment includes the middle-market equipment leasing business and small-ticket financing business. It generates a majority of its revenue from the Franchising segment.

About NBTX Nanobiotix S.A.

Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.

Share on Social Networks: